Next Generation Flow for highly sensitive and standardized detection of minimal residual disease in multiple myeloma

Juan Flores-Montero,Luzalba Sanoja-Flores,Bruno Paiva,Noemi Puig,García-Sánchez O,Sebastian Böttcher,van der Velden Vhj,Pérez-Morán Jj,M. B. Vidriales,Ramón García-Sanz,Carmen Jiménez,Marcos González,Joaquín Martínez López,A. Corral-Mateos,Georgiana Grigore,R Fluxá,R. Pontes,Joana Caetano,Łukasz Sędek,del Cañizo Mc,J. Blade,Juan José Lahuerta,Carlos Aguilar,Abelardo Barez,Aránzazu García Mateo,Jorge Labrador,Pilar Leoz,Aguilera Sanz C,Jesús F. San Miguel,Maria-Victoria Mateos,Brian G. M. Durie,van Dongen Jjm,A. Orfao

Next Generation Flow for highly sensitive and standardized detection of minimal residual disease in multiple myeloma

2017

This work has been supported by the International Myeloma Foundation-Black Swan Research Initiative, the Red Tematica de Investigacion Cooperativa en Cancer (RTICC); grant SA079U14 from the Consejeria de Educacion, Junta de Castilla y Leon, Valladolid, Spain and; grant DTS15/00119 from Instituto de Salud Carlos III, Ministerio de Economia y Competitividad, Madrid, Spain.

Keywords:

Cancer research
Minimal residual disease
Cancer
Immunology
Medicine
Multiple myeloma
treatment outcome
highly sensitive
research initiative
Humanities

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

281

Citations